Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

5 Value Stocks In The Healthcare Sector

Author: Benzinga Insights | August 01, 2022 11:06am

What is a Value Stock?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

  1. Achilles Therapeutics (NASDAQ:ACHL) - P/E: 0.44
  2. Sensus Healthcare (NASDAQ:SRTS) - P/E: 8.73
  3. Global Cord Blood (NYSE:CO) - P/E: 4.01
  4. BioNTech (NASDAQ:BNTX) - P/E: 3.27
  5. Fonar (NASDAQ:FONR) - P/E: 9.48

Achilles Therapeutics has been featured as a value stock. Achilles Therapeutics's Q1 EPS sits at $-0.45, which has not changed since last quarter (Q4). Sensus Healthcare saw a decrease in earnings per share from 0.32 in Q4 to $0.2 now. This quarter, Global Cord Blood experienced a decrease in earnings per share, which was $0.17 in Q3 and is now $0.14. BioNTech has reported Q1 earnings per share at $15.97, which has increased by 14.64% compared to Q4, which was 13.93. Most recently, Fonar reported earnings per share at $0.32, whereas in Q2 earnings per share sat at $0.57.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Posted In: ACHL BNTX CO FONR SRTS